Recent Advances and Innovations in Epilepsy Management: A Comprehensive Update for Healthcare Professionals
OthersPage Navigation
Introduction
As our understanding of epilepsy deepens, so does the sophistication of its management strategies. This article will explore recent advancements and innovations in epilepsy management.
New Antiepileptic Drugs
Several new antiepileptic drugs (AEDs) have been introduced, offering better seizure control with fewer side effects. These include Brivaracetam, Perampanel, and Lacosamide.
Neuromodulation Techniques
Neuromodulation techniques, such as Vagus Nerve Stimulation (VNS) and Responsive Neurostimulation (RNS), are proving effective in reducing seizure frequency and severity.
Advances in Surgical Techniques
Minimally invasive surgical techniques, such as Laser Interstitial Thermal Therapy (LITT), have emerged as promising alternatives to traditional resective surgery for drug-resistant epilepsy.
Genetic Testing
Genetic testing is increasingly used to diagnose and guide treatment of certain forms of epilepsy, particularly in children.
Conclusion
These advancements are revolutionizing epilepsy management, offering hope for improved quality of life for patients. Continued research and innovation are essential to further refine these strategies.
Recommended News For You
Recommended Articles For You
Featured News
Featured Articles
Featured Events
Featured KOL Videos
1.
Prostate cancer detection with PET CT and PET MRI is comparable.
2.
Refractory Multiple Myeloma Responsive to Immunotherapy Plus Low-Dose Radiotherapy
3.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
4.
In NSCLC, subcutaneous Lazertinib + Amivantamab Dosing Is Not Worse Than IV Dosing.
5.
Loncastuximab-Rituximab Boosts Response Rates in R/R Follicular Lymphoma
1.
Innovative Intraoperative Therapies in Neurosurgical Oncology: Advancing Precision and Outcomes
2.
Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer
3.
Holistic Oncology: Advancing Survivorship, Nursing, and Innovative Cancer Care Models
4.
Emerging Chemo-Immunotherapy: New Agents and Mechanisms in Modern Oncology
5.
The Dangers of Supratherapeutic INR: The Need for Increased Awareness and Monitoring
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Thromboprophylaxis In Medical Settings
2.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
4.
Efficient Management of First line ALK-rearranged NSCLC
5.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Welcome to Hidoc Dr.
Join to enhance your clinical skills and gain specialized in-depth medical knowledge